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The myxoma virus M063R gene product exhibits some sequence similarity to the poxvirus host range gene, C7L, of vaccinia virus. To address
the potential host range function of the M063R gene product in rabbits, a deletion mutant of myxoma virus (vMyx63KO) was generated and
characterized. vMyx63KO replicated to normal titre levels and produced foci that were indistinguishable from those produced by MV in vitro in a
monkey kidney cell line (BGMK) that are permissive for wild type MV. However, vMyx63KO failed to replicate in all rabbit cell lines tested,
including both primary and established cells lines, as well as cells derived from a variety of tissues. M063R expression was not required for
myxoma virus binding, entry or early gene expression, whereas DNA replication was aborted and late genes were not expressed in vMyx63KO
infected rabbit cells. Thus, the replication block for vMyx63KO in rabbit cells preceded the stage of late gene expression and DNA replication.
Finally, an in vivo pathogenesis study indicated that vMyx63KO failed to cause any signs of classic myxomatosis in infected rabbits, but
functioned as a non-replicating vaccine and provided protection for subsequent challenge by wild type myxoma virus. Altogether, these
observations demonstrate that M063R plays a critical role in determining the host specificity of myxoma virus in rabbit cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: Poxvirus tropism; Pathogenesis; Vaccinia C7L; Host range factorIntroduction
Myxoma virus (MV), a large DNA virus of the leporipox-
virus genus of the poxviridae family, is the etiological agent
responsible for lethal myxomatosis in European rabbits
(Oryctolagus cuniculus) (Fenner and Ratcliffe, 1965). Myxoma
virus infection of its evolutionary rabbit hosts, members of the
genus Sylvilagus, results in the production of localized, benign
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doi:10.1016/j.virol.2006.11.015contrast, MV infection of its pathogenic host, O. cuniculus
results in myxomatosis and death. Although MV has been used
as a biological agent to control feral O. cuniculus rabbit popu-
lations in Australia (Fenner and Ratcliffe, 1965) and there is
almost 50 years of data about the co-evolution of virus and host
(Best et al., 2000; Best and Kerr, 2000; Kerr and Best, 1998),
the factors that mediate the tropism of myxoma virus for rabbits
remain unknown. Prior to the sequencing of the myxoma virus
genome sequence, only a few leporipoxvirus genes, such as M-
T2, M-T4, M-T5 and M11L had been demonstrated to possess
host range functions (Barry et al., 1997; Macen et al., 1996;
Mossman et al., 1996). However, these are best described as
tissue-specific host range genes, as they only restrict virus
replication in rabbit lymphocytes (RL5). Our analysis of the
MV genome revealed that multiple tandemly organized ORFs,
including M062R, M063R and M064R, were predicted to be
related to other known poxvirus host range genes (Barrett et al.,
2001; Cameron et al., 1999).
Fig. 1. Amino acid sequence alignment of myxoma virus M063R (Genbank accession number AAF14951.1) against M062R, M064R and vaccinia virus C7L. The
amino acid sequences were aligned using the ClustalW Alignment function of MacVector (version 6.5.3, Oxford Molecular Ltd.). Dark and light shaded boxes
represent the identical and similar amino acid residues among these three proteins, respectively.
Table 1
Percentage identity and similarity among various poxvirus host range genes
M062R M063R M064R C7L K1L CHOhr CF8a
M062R – 21/40 a 30/42 28/43 12/21 6/10 30/45
M063R – – 21/40 14/30 16/24 7/11 22/48
M064R – – – 19/36 12/22 7/11 33/48
C7L – – – – 10/20 7/11 26/45
K1L – – – – – 12/19 10/21
CHOhr – – – – – – 8/12
a The numerator indicates the percentage identity, whereas the denominator
shows the percentage similarity between the two compared sequences. In each
instance, the amino acid sequences were aligned using ClustalW alignment
function of MacVector (version 6.3.5, Oxford Molecular Ltd.).
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primarily from the study of the C7L and K1L ORFs of
vaccinia virus and CHOhr from cowpox (Perkus et al., 1989,
1990a; Spehner et al., 1988). For example, loss of both C7L
and K1L expression from vaccinia virus abrogated the virus
ability to replicate in human cells, while deletion of either gene
on its own did not block replication, suggesting that they
possess redundant or synergistic functions in human cells
(Perkus et al., 1990b; Ramsey-Ewing and Moss, 1996). On the
other hand, deletion of K1L alone is sufficient to prevent
vaccinia virus replication in the rabbit cell line, RK13 cells
(Perkus et al., 1990a; Ramsey-Ewing and Moss, 1996). The
host range significance for vaccinia virus was further
demonstrated by the observation that restoration of the K1L
ORF into the highly attenuated modified vaccinia virus strain
Ankara, (MVA) permitted this strain to replicate in normally
non-permissive RK13 cells (Sutter et al., 1994; Wyatt et al.,
1998). Another well studied orthopox host range gene, the
cowpox 77 kDa protein encoded by the CHOhr gene, was
required for cowpox replication in Chinese hamster ovary
(CHO) cells (Spehner et al., 1988). The CHOhr ORF could also
functionally replace K1L and permit vaccinia virus replication
in RK13, suggesting that expression of CHOhr also possessed
rabbit cell host range function (Ramsey-Ewing and Moss,
1996).
Since rabbits are the natural host for leporipoxviruses, it was
surprising that myxoma virus did not encode an obvious K1L or
CHOhr homologue (Cameron et al., 1999). Instead, we
identified three ORFs, designated M062R, M063R and
M064R, that are tandemly arranged in the center region of the
myxoma virus genome and share some sequence similarity to
vaccinia virus C7L (Cameron et al., 1999). Since C7L is not
required for vaccinia virus replication in rabbit cells, and
because M063R shows the least similarity to C7L among the
three myxoma C7L-like homologues (Cameron et al., 1999), we
reasoned that M063R might possess unique rabbit host range
functions. Here, we provide evidence that M063R functions as arabbit-specific host range gene and is obligatory for productive
myxoma virus replication in all rabbit cells tested and absolutely
required for development of myxomatosis.
Results
M063R belongs to a cluster of predicted host range genes
The myxoma virus gene product M063R was identified
during the sequencing of the MV genome as one of three genes
(M062R, M063R, M064R) that formed a cluster adjacent to the
thymidine kinase gene (M061R) and appeared to be related to
each other (Cameron et al., 1999). Sequence alignment (Fig. 1)
suggested that M062R and M064R were more similar to each
other and to the VV host range gene, C7L (Table 1) then any of
them were to M063R. This was confirmed by identity/
similarity comparisons amongst the three MV gene products
and VVC7L (Table 1). M063R was the least similar ORF
amongst the three MV ORFs. M063R contains a 24-residue
insert in the middle of the ORF and encodes an acidic carboxy
terminus. Sixty-four percent of the last 25 residues are either
glutamic acid (E) or aspartic acid (D) (Fig. 1). The M062R–
M063R–M064R ORF cluster was predicted to represent host
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ORF C7L and the capripox virus CF8a (Gershon and Black,
1989).
Screening of the M063R sequence through several online
programs indicated that M063R did not encode a predicted
signal sequence (SIGNAL P [www.cbs.dtu.dk/services/SignalP/
]), did not have any transmembrane domains (TM Pred, [www.
ch.embnet.org/software/TMPRED_form.html]), did not encode
any ankyrin or other repeats (www.embl-heidelberg.de/
~andrade/papers/rep/search.html) and had no predicted N-
linked glycosylation sites (MacVector). A recent blast search
of the NCBI protein database with M063R found that M063R is
most similar to numerous poxvirus orthologs including gp63
from Shope fibroma virus (Willer et al., 1999), followed by
M062R from MV (Cameron et al., 1999) and the Yatapoxvirus
67R orthologs (Brunetti et al., 2003; Lee et al., 2001). The
M063R gene product shared 65% identity (77% similarity) with
the SFV gp63 gene product however SFV gp63 was missing
12 amino acids including 9 acidic residues from the carboxy
terminus.Fig. 2. Expression of M063R. (A) A Kyte–Doolittle hydrophilicity plot of M063R
residues 140 and 160 represents the 14 residue peptide identified between amino acid
raise polyclonal antisera against M063R. (B) Rabbit fibroblasts (RK13) cells were in
points indicated. The left panel represents a time course experiment (lanes 1–6) in wh
expression. The right panel (lanes 7–9) represents M063R expression at 2 and 24 hpi
cytosine 1-β-D-arabinofuranoside (AraC, 40 μl/ml; lane 9). M063R was detected with
for expression of the myxoma virus late gene product, Serp1 to confirm that AraC tre
M063R following infection (panel 1), transfection (panel 2) or transfection and immun
in a doublet.M063R is expressed early but expression continues throughout
the virus life cycle
Analysis of the promoter sequences of the myxoma ORFs
originally assigned the promoter of M063R as early (Cameron
et al., 1999). To confirm this prediction we infected rabbit
kidney fibroblasts (RK13) with vMyxlac and collected infected
cells at various times post infection and using a peptide
antibody raised against a hydrophilic region of M063R
(Fig. 2A) we probed for M063R expression. M063R was
detected by 4 hpi and the level of detected protein increased
over time (Fig. 2B, lanes 1–6). To confirm that M063R was
synthesized as an early gene, infected RK13 cells were treated
with AraC+ following the 1 h virus adsorption. Contrary to
expectation for an exclusive early gene, the level of detected
M063R protein was noticeably less following the treatment with
AraC (Fig. 2B, compare lanes 8 and 9). AraC acts to block DNA
synthesis but early viral gene synthesis is not dependent upon
DNA replication and there should be no change in detected
protein levels unless the mRNA is particularly unstable. The. The solid bar and amino acid sequence above the hydrophilic peak between
s 147 and 160 that was synthesized (Invitrogen), conjugated to KLH and used to
fected with vMyxlac (moi=5) and infected cells were collected at various time
ich the anti-M063R peptide antibody described above was used to detect M063R
following either no treatment (lanes 7 and 8) or treatment of ectopically applied
the anti-M063R peptide antibody. The membrane was then stripped and probed
atment had completely blocked late expression of viral proteins. (C) Detection of
oprecipitation (panel 3) with the peptide antibody against M063R always results
Fig. 3. Construction and characterization of the M063R deletion mutant
(vMyx63KO). (A) Schematic representation of the construction and (B) PCR
analysis of the M063R deletion mutant. The left (primers JB18.03×JB19.03,
LFR) and right (JB20.03×JB21.03, RFR) flanking fragments of M063R were
amplified from myxoma virus genomic DNA. The M063R LFR encodes the
entire M062R open reading frame (ORF), but the M063R ORF was truncated
immediately after amino acid residue 24. The M063R RFR contains sequences
encoding the last 28 amino acids of M063R and the entire M064R ORF. The
PstI/EcoRI fragment containing the pE/L-EGFP selection marker was used to
replace the M063R ORF. The disrupted M063R ORF was introduced into the
wild type myxoma virus genome (vMyxLau) through homologous recombina-
tion and recombinants were identified and purified by plaque purification of
fluorescent green foci. (B) PCR confirmation of purification of vMyx63KO.
The M063R region was amplified (primers JB13.05×JB14.05, 3A). Lane 1
represents the 645 bp amplification of wildtype M063R. Lane 2 represents
amplification (JB13.05×JB14.05) of the same region from pure vMyx63KO.
This larger PCR product contains both the deleted M063R coding region and
the EGFP cassette. There is no evidence of the intact M063R and indicates that
vMyx63KO is pure. (C) Immunoblotting to confirm loss of M063R expression.
RK13 cells were infected with either vMyxgfp or vMyx63KO at an moi=3 and
samples were collected at the times indicated. The membrane was probed with
anti-M063R, stripped and probed with anti-M-T7 and then stripped and probed
with anti-Serp1.
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M063R may represent an early/late gene product whose
continued expression relies on DNA synthesis.
Another unexpected observation following immunoblotting
of infected RK13 cell lysates was the detection of two bands
corresponding to M063R that were detected by the polyclonal
antibody. This appearance of two bands, corresponding to
M063R, was observed following infections, transfections or
immunopreciptiations with the anti-63 polyclonal antibody
(Fig. 2C). These two bands may represent an unphosphorylated
(lower band) and phosphorylated (higher band) state, or some
other post-translational modification.
M063R is required for viral replication and transition to late
gene expression in rabbit cells
To elucidate the role of M063R during MV infection we
constructed a knockout virus in the wildtype myxoma virus
(vMyxLau) background in which 76% of the coding region of
M063R was deleted and replaced by an EGFP cassette under the
control of the VV synE/L promoter (Chakrabarti et al., 1997). A
schematic diagram illustrates the construction of the knockout
virus, vMyx63KO, and the orientation of the selection marker
(Fig. 3A). The purity of the knockout was confirmed by PCR
using primers that bind to the 5′ and 3′ ends of M063R to
amplify the coding region (Fig. 3B). This results in a 645 bp
product for the wildtype template (Fig. 3B, lane 1) and a 1.3 kb
product including the partial M063R (minus deletion) and the
gfp cassette (Fig. 3B, lane 2). There was no sign of wildtype
M063R in the knockout sample. vMyx63KO was amplified and
titrated on non-human primate cells (BGMK). However when
we infected rabbit fibroblasts with vMyx63KO there was no
evidence of virus amplification or expression (Fig. 3C, compare
lanes 1-6 versus lanes 7-12, top panel). This inability of
vMyx63KO to replicate in rabbit cells was confirmed in a series
of established and primary rabbit cell lines. In no case was there
any sign of vMyx63KO replication (Table 2). In contrast, there
was little or no difference in the ability of vMyx63KO to
replicate in the cells of other species or cell types. For example,
infection of human cancer cells with vMyxgfp or vMyx63KO
did not respond any differently for the synthesis of an MV
secreted late gene (Fig. 4).
To examine this issue we performed single- and multi-
step growth curves to determine whether there was a
replication or spread defect in vMyx63KO. Permissive
(BGMK) and non-permissive (RK13) cells were infected
with either vMyxgfp or vMyx63KO at an moi=3 (single-
step) or moi=0.01 (multi-step) and infected cells were
collected at various times post infection. Both viruses
replicated efficiently and to similar levels in the permissive
BGMKs (Fig. 5A, left panel). Replication of vMyxgfp on
RK13 cells produced replication kinetics similar to what
was observed on BGMK (Fig. 5A, right panel). In contrast
vMyx63KO exhibited a growth curve that suggested that the
virus entered the cell, underwent virus uncoating followed
by an abortive replication cycle as the virus titer did not
increase over time (Fig. 5A, right panel).
Fig. 4. M063R expression is not required for MV infection of human cancer
cells. Various human cancer cells were left uninfected (lane 1) or infected with
either vMyxgfp (lane 2) or vMyx63KO (lane 3). At 16 hpi the supernatants were
collected, concentrated 10× and then immunoblotted with an antibody against
the MV secreted, late gene Serp1. Western blot analysis suggests that there is not
a block to MV DNA replication in human cancer cells that was observed in the
rabbit cells.
Table 2
Replication of vMyxLau and vMyx63KO in cell lines derived from various
species and tissues
Cell line Cell type Wild type myxoma a vMyx63KOa
BGMK Monkey kidney 246±8.40 216±7.20
BSC-40 Monkey kidney 195±9.50 223±11.9
Hig-82 Rabbit synoviocyte 82.7±11.1 No foci
RK13 Rabbit kidney fibroblast 170±12.1 No foci
SIRC Rabbit cornea fibroblast 115±8.54 No foci
RL-5 Rabbit CD4+ T cell 3.52±0.28 b No foci
HOS c Human osteosarcoma 169±10.4 45.7±6.00
3T3 c Mouse fibroblast 274±8.02 66.0±9.16
a Each cell line, except RK13 and SIRC, was infected with either myxoma
virus (wild type) or M063R deletion mutant at a moi of 0.0005 in triplicate for
4 days. For both RK13 and SIRC, they were infected for 3 days. The infected
cells were then fixed and stained with 0.05% crystal violet. The number of
myxoma foci per well was then enumerated.
b The RL-5 cells were first infected with the respective virus at a moi of 1 for
3 days. The virus titres (at 105 pfu/ml) were then determined on BGMK.
c The 3T3 and HOS cell lines were infected with the respective virus at a moi
of 0.005 for 3 days.
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curves. Briefly, both viruses exhibited identical transmission
kinetics in BGMK cells and reached similar titers (Fig. 5B, left
panel). In contrast, vMyxgfp and vMyx63KO exhibited
divergent viral spread in RK13 cells. The spread of vMyxgfp
was as expected and the virus titer increased 3 logs over 2 days
(Fig. 5B, right panel). In contrast, the spread of vMyx63KO was
non-existent and following virus entry the titre of vMyx63KO
fell to non-detectable levels (Fig. 5B, right panel).
In order to evaluate where the block to virus replication
occurred we again infected both BGMK and RK13 cells with
vMyxgfp or vMyx63KO at a high moi and left the cells untreated
or added AraC (40 μg/ml) following virus adsorption. Infected
cells were collected 2 or 24 hpi and then immunoblotted with
anti-M-T7, a strongly expressed, secreted, MVearly gene product
or with anti-Serp1 which represents a MV secreted, late gene
product. The early MV gene product, M-T7 was detectable at
2 hpi and was readily detectable at 24 hpi regardless of the virus
or cell line used and with or without the addition of AraC (Fig. 6,
top panel). In contrast, Serp1 was not detectable in any cell line at
at the early time point of 2 hpi (Fig. 6, lanes 1, 4, 7, 10) or when
DNA synthesis was blocked by the addition of AraC (Fig. 6,
lanes 2, 5, 9, 12). Serp1 was detected by 24 hpi in the permissive
BGMK cells infected with either vMyxgfp or vMyx63KO (Fig.
6, lanes 8 and 11, lower panel) and Serp1 was also detected in
RK13 cells infected with vMyxgfp (Fig. 6, lane 3, lower panel).
However, Serp1 was not detectable at 24 hpi in the restrictive
RK13 cells infected with vMyx63KO (Fig. 6, lane 6). These data
indicate that the expression of M063R is required for productive
infection of rabbit cells in vitro. vMyx63KO binds and enters
cells normally and uncoats, however in rabbit cells there is a
block prior to virus replication and virus late gene expression.
Expression of VV K1L cannot rescue vMyx63KO
In order to test whether the VV host range gene product K1L
could rescue MV replication in the absence of M063Rexpression we employed rabbit fibroblasts that stably express
K1L (Sutter et al., 1994). We infected RK13, primary rabbit
embryo fibroblasts (REF), and RK13/K1L cells with either
vMyxgfp or vMyx63KO at a low moi and 48 hpi we scored foci
for number and size. As expected, vMyxgfp produced normal
foci on all three cell lines (not shown). In contrast, vMyx63KO
did not replicate or form foci on any of the cells. This
demonstrates that RK13 cells that stably express K1L, the VV
gene product required for VV replication in rabbit cells, cannot
relieve the block for MV replication when M063R is not
expressed. Therefore, K1L and M063R are not interchangeable
and likely act on different cellular targets.
M063R is required for myxomatosis in O. cuniculus
Although M063R expression is necessary for MV replication
in cultured rabbit cells, it was necessary to test the requirement of
M063R expression for MV replication in the relevant patholo-
gical host. To address this, a pathogenesis study of vMyx63KO
infection of O. cuniculus was carried out. Two groups of four
female New Zealand white rabbits (O. cuniculus) were injected
subcutaneously with 1000 pfu per flank with either vMyxgfp or
vMyx63KO. Rabbits were examined daily and monitored for
symptoms of myxomatosis. As outlined in Table 3, vMyx63KO
was avirulent and induced no detectable signs of myxomatosis in
infected rabbits. In fact, no primary lesionwas detected at the site
of injection in rabbits infected with vMyx63KO, suggesting that
the mutant failed to replicate significantly in the inoculated sites
of infected rabbits. This was in sharp contrast to the control
animals infected with wild type virus (vMyxgfp). The primary
lesion on the control animals was evident 4 days post-infection
in rabbits injected with vMyxgfp. By day 6, conjunctivita were
detected in MV infected rabbits, while by day 9 post-infection,
severe signs of myxomatosis were observed in all of the rabbits
infected with wild type virus. These observations correlated well
with the in vitro data, which demonstrated that M063R is
essential for MV propagation in rabbit cells. Additionally,
Fig. 6. Analysis of the replication block of vMyx63KO in RK13 cells. BGMK
(lanes 7–12) and RK13 (lanes 1–6) cells were infected with vMyxgfp (lanes 1–3
and 7–9) or vMyx63KO (lanes 4–6 and 9–12). Infected monolayers were left
untreated (lanes 1, 3, 4, 6, 7, 8, 10, 11) or treated with Ara C (lanes 2, 5, 9, 12)
following infection. Infected supernatants were collected 2 hpi (lanes 1, 4, 7, 10)
or 24 hpi (lanes 2, 3, 5, 6, 8, 9, 11, 12). The presence of the myxoma virus early,
indicating virus entry and uncoating, and late proteins, representing virus
replication, were detected using anti-M-T7 and anti-SERP-1 antibodies,
respectively.
Fig. 5. Growth kinetics of vMyxgfp and vMyx63KO in permissive and vMyxgfp, vMyx63KO and vMyx63Rev in non-permissive cells. (A) Cells were infected with
vMyxgfp or vMyx63KO at a high moi (moi=3) or with vMyx63Rev at an moi=1. Replication of vMyxgfp (solid black line) and vMyx63KO (dashed black line) was
evaluated in permissive (BGMK cells, left panel) and restrictive (RK13 cells, right panel) cells. The growth kinetics of the M063R revertant, vMyx63Rev (solid grey
line) was tested in the non-permissive cells (RK13) only. (B) To examine virus spread cells were infected with a low moi (moi=0.01) and infection was evaluated with
the same viruses as above in the same cells lines as indicated above.
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by the wild type myxoma virus infection.
This suggests that the mutant virus could function as a non-
replicating vaccine vector against myxomatosis. Although it is
strictly possible to describe M063R as a virulence factor for
myxomatosis pathogenesis, it is best classified as a rabbit
specific host range factor.
To confirm that the deletion of M063R resulted in the
complete attenuation of vMyx63KO in the rabbit model we
generated a revertant virus in which M063R was restored
(vMyx63Rev). We tested the ability of vMyx63Rev to restore
the biological features of wildtype myxoma virus including
infection of rabbit cells and development of classic myxoma-
tosis in infected rabbits. Single- and multi-step growth curves of
vMyx63Rev replication and spread in RK13 cells, which do not
support vMyx63KO replication (Fig. 5) indicated that restora-
tion of M063R expression also rescued the ability of the
revertant to replicate and spread in rabbit cells (Figs. 5A and B,
right panels). Injection of O. cuniculus with vMyx63Rev
Table 3
Pathogenicity of myxoma virus (vMyxgfp) and M063R deletion mutant (vMyx63KO in infected New Zealand White rabbits)
Day vMyxgfp vMyx63KO vMyx63Rev
0 Four adult female NZW rabbits were inoculated
intradermally at two sites with 103 pfu/site.
Four adult female NZW rabbits were
inoculated intradermally at two sites
with 103 pfu/site.
Three adult female NZW rabbits were inoculated
intradermally at two sites with 103 pfu/site.
3 Primary lesions with an average diameter of
1 cm were detected in all rabbits.
No sign of primary lesion. Primary lesions with an average diameter of
1 cm were detected in all rabbits.
5 Primary lesions increased in diameter to
2–3 cm and started to become necrotic.
No sign of primary lesion. Primary lesions large, red with black center,
first sign of 2° lesion on nose and eyelid.
7 Primary lesion increased in diameter to
3–3.5 cm. Numerous satellite lesions were
detected surrounding the primary lesions.
Secondary lesions were also detected in
genitals and noses.
No sign of primary lesion. Signs of myxomatosis obvious including ruffled
fur, swollen heads and secondary lesions in ears,
on nose and on eyelids.
9 and 10 Severe signs of myxomatosis. Primary
lesions in all rabbits were approximately
4 cm in diameter. Numerous satellite lesions
were evidenced in ears, noses and mouths.
Conjunctivita were also detected. Rabbits
were sacrificed due to severity of the
symptoms.
No sign of disease. All of the rabbits
remained healthy.
Severe signs of myxomatosis. Primary lesions in
all rabbits were approximately 4 cm in diameter.
Numerous satellite lesions were evidenced in
ears, noses and mouths. Conjunctivita were
also detected. Rabbits were sacrificed due to
severity of the symptoms.
14 Rabbits were re-challenged intradermally
with wild type myxoma virus
(103 pfu/injection site).
No signs of myxomatosis were detected in
these wild type virus re-challenged
rabbits. Therefore deletion mutant will
make an ideal vaccine.
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myxomatosis (Table 3).
M063R does not inhibit apoptosis in a caspase dependent
manner in RK13 cells
We hypothesized that the requirement of M063R expression
for virus replication in cultured and primary rabbit cells
suggested a role in blocking an apoptotic response. To test
this hypothesis we infected rabbit kidney (RK13) cells with
either vMyxlac or vMyx63KO at an moi=5 and collected
infected cells at various times post infection and immunoblotted
for caspase 3 cleavage. Contrary to this expectation, there was
no detectable caspase 3 cleavage indicating that loss of M063
expression did not induce a caspase dependent apoptotic
pathway (Fig. 7A).
To test whether the expression of M063R functioned to block
apoptosis in a caspase-independent manner, we examined the
ability of MV to block TNF induced apoptosis in HeLa cells.
Again, there was no indication that the presence and expression
of M063R had any role in blocking TNF induced apoptosis
because PARP cleavage appeared the same in all samples (Fig.
7B; compare lanes 2, 4 and 6). As noted above MV is unable to
productively replicate in RK13 cells. Therefore to test whether
M063R expression was involved in signaling pathways we
selected two important signaling molecules to test their levels of
activation in the presence and absence of M063R expression.
RK13 cells infected with vMyx63KO or vMyxgfp do not
appear to respond any differently when we examined levels of
activated IκB or P27 (Fig. 7C).Discussion
Myxoma virus does not encode an obvious rabbit host gene
homologue of the vaccinia virus K1L gene family. However,
our data suggest that the M063R ORF has assumed the
equivalent host range function for rabbit cells. This is supported
by the fact that deletion of M063R is sufficient to prevent
myxoma virus from replicating in all rabbit cell lines tested.
However, M063R expression is not necessary for vMyx63KO
infection of human cancer cells and primate cells like BGMK.
Since M063R is absolutely required for myxoma virus
replication in rabbit but not non-human primate cells, this
suggests that either M063R must interact with some yet to be
identified rabbit cellular components or else the permissive cells
are deficient in some aspect of induction of an anti-viral state.
At present, we presume that the cellular pathway that M063R
interacts with must be somehow different or absent in monkey
kidney cells (BGMK) or human osteosacroma cells (HOS), both
of which are permissive for vMyx63KO. It is noteworthy that
the Shope fibroma virus encodes a shorter version of M063R
homologue consisting of only 203 amino acids instead of 215
(Willer et al., 1999). Twelve of the missing amino acids of
S063R are located at the C-terminus of the polypeptide, and
which is highly acidic in M063R. Nevertheless, this suggests
that even though the M063R protein is critical for leporipox-
virus replication in rabbit cells, it can tolerate a certain degree of
variability in its primary sequence.
Unlike vaccinia virus, myxoma virus exhibits a narrow host
range. It remains unclear why leporipoxviruses encode three
copies of the C7L-like homologues (Cameron et al., 1999;
Fig. 7. M063R does not act to inhibit apoptosis. (A) RK13 cells were infected
with either vMyxlac or vMyx63KO at an moi=5 and then infected cells were
collected at various times post infection. Whole cell lysates were prepared and
separated on a 12% SDS-PAGE gel. Immunoblotting with anti-caspase 3 (top
panel) or anti-actin (lower panel) indicated no difference in the samples. (B)
HeLa cells, mock infected (lanes 1, 2) or infected with either vMyxlac (lanes
3,4) or vMyx63KO (lanes 5, 6) were left untreated (lanes 1, 3, 5) or treated with
TNF (2 μg/ml) and CHX (30 μg/ml) (lanes 2, 4, 6) and collected 18 hpi. The
proteins were separated on an 8% SDS-PAGE gel and probed with anti-PARP.
(C) RK13 cells were treated as in (A) and then probed with anti-P27 or anti-IκB.
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sufficient to restrict myxoma virus replication in rabbit cells.
Nevertheless, it is clear that these myxoma virus C7L
homologues are not functionally equivalent, as the remaining
M062R and M064R ORFs failed to rescue vMyx63KO from
replicating in rabbit cells. The functional relationship among
M062R, M063R and M064R remains to be investigated further.
However, the presence of this apparent gene triplication could
also provide an explanation for the narrow host range of
leporipoxviruses in the wild. For instance, it is possible that
each of these C7L-like gene products interact with distinct
rabbit cellular components in order to have a productive virus
replication cycle. If this is correct, then removal of any one of
these genes might render the virus incapable of replicating in
rabbit cells. The genome sequence of other poxviruses revealed
that only a single C7L-like ORF is present in members of the
orthopox-, capripox-, suipox-, and yatapoxviruses (Afonso
et al., 2002; Brunetti et al., 2003; Lee et al., 2001; Tulman et al.,
2001). The members of these poxvirus genera, with the
exception of vaccinia, also have narrow host ranges in the
wild. For these poxviruses, it seems that a single copy of C7L-
like gene is sufficient to confer the host range restriction
functions. Whether deletion of this single C7L-like ORF in
these poxviruses would render them incapable of replicating in
their natural hosts remains to be determined.
The M063R deletion mutant, vMyx63KO is the most
attenuated myxoma virus single gene knockout mutant reported
to date. Among all of the other reported deletion mutants ofmyxoma virus, vMyx63KO is the only virus to fail to induce
any detectable primary lesion formation in infected rabbits. The
myxoma tissue-specific host range genes M-T2, M-T4, M-T5
and M11L are known to have anti-apoptotic functions and they
are essential for a productive replication cycle in rabbit
leukocytes (Barry et al., 1997; Macen et al., 1996; Mossman
et al., 1996). It is possible that M063R might possess a similar
anti-apoptotic function, however our preliminary observations
do not support this argument. For example, RK13 and RL-5
cells infected with a high moi of vMyx63KO were able to
undergo subsequent cell division and increase in cell number,
rather than undergo apoptotic death (Fig. 7 and data not
shown). Although the lack of an anti-apoptotic function for
M063R remains to be formally demonstrated, it is noteworthy
that K1L exerts its function in a pathway distinct from that of
apoptosis (Chung et al., 1997). Deletion of the SPI-1 host range
factor from rabbitpox and infection of non-permissive cells
resulted in morphological features of apoptosis but a failure to
activate terminal caspases or PARP cleavage (Moon et al.,
1999). Since vMyx63KO was able to bind and enter the cell
and undergo early protein synthesis, it is clear that M063R is
not required for early gene transcription and translation.
However, our data cannot exclude the possibility that M063R
may be required for core uncoating, late stage transcription/
translation or DNA replication. For instance, K1L has been
implicated in activating viral transcription, and host factors are
known to be involved in vaccinia virus late gene transcription
(Gunasinghe et al., 1998; Rosales et al., 1994; Sutter et al.,
1994; Zhu et al., 1998). The presence of early, but not late,
proteins in vMyx63KO infected RK13 cells is reminiscent to
that host range phenotype of CHOhr and K1L (Ramsey-Ewing
and Moss, 1995). In addition, both vMyx63KO and vaccinia
virus K1L− mutant failed to undergo DNA replication in RK13
(Ramsey-Ewing and Moss, 1995). One can speculate that both
K1L and M063R exert their effect on the same host range
regulatory pathway and both mutants encounter the same
replication block in rabbit cells. Furthermore, since myxoma
virus has a narrow host range, it should be a good model to
examine the functional relationship between a host range gene
and its natural host.
Materials and methods
Cells and viruses
BGMK,RK13, HeLa, HEK293 and CV1 cells weremaintained
in Dulbecco's modified Eagle medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 100 U penicillin/ml and
100 μg streptomycin/ml. The human cancer cells (OVCAR5,
SK-OV-3, Caki-1, HOS, 786-0) are part of the NCI-60
collection and were obtained from John Bell (University of
Ottawa). All five cells lines were maintained as above. RK13/
K1L cells have been described previously (Sutter et al., 1994)
and were maintained as above in media supplemented with
800 μg/ml G418. RL5 cells were grown in RPMI 1640 medium
supplemented with 10% FBS, 100 U penicillin/ml and 100 μg
streptomycin/ml. Recombinant viruses used in this study
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have been described elsewhere (Johnston and McFadden, 2003;
Opgenorth et al., 1992).
Construction of recombinant myxoma viruses
To construct vMyx63KOprimers were synthesized (Sigma) to
amplify regions flanking the M063R locus. The left (603 bp)
flank was amplified with primers JB18.03 5′-GCGGGATC-
CATGGGCGTGCAACACAAATTGG-3′ (BamHI underlined)
and JB19.03 5′-GCGCTGCAGGGGCCCGCGTTTTTAATA-
GACAGG-3′ (PstI underlined). The right (779 bp) flank was
amplified with primers JB20.03 5′-GCGGAATTCTCGATCG-
TAGACAGTAGCGATAGC-3′ (EcoRI underlined) and JB21.03
5′-GCGAAGCTTCTAATCTTCTGCATCTTTTTGGTTATC-
3′ (HindIII underlined) from MV template DNA. The PCR
products representing the flanking regions were digested with
BamHI and PstI (left flank) or EcoRI and HindIII (right flank)
and cloned directly, but sequentially into pBluescript containing
the enhanced green fluorescent protein (EGFP) cassette (pBS:
EGFP) linearized with the corresponding restriction enzymes.
pBS:EGFP carries the EGFP cassette under the syn E/L poxviral
promoter was had previously been cloned into pBluescript at the
Pst1 and EcoRI sites.
To construct the revertant we constructed two transfer
vectors. We first amplified a 1.836 kb region, using primers
JB18.03 and JB21.03, from the wildtype myxoma virus
template. The amplified fragment corresponded to the region
surrounding M063R and included the complete M063R open
reading frame. This fragment was cloned into the BamHI and
HindIII sites of pBluescript generating the transfer plasmid
pBS:63Rev. BGMK cells were infected with vMyx63KO and
1 h later the infected cells were transfected with pBS:63Rev and
a second plasmid containing a yellow fluorescent protein
(YFP) cassette under the vaccinia synthetic early/late
promoter and cloned between the M135 and M136 open
reading frames. Only viruses that represented homologous
recombination between pBS:63Rev and vMyx63KO, resulting
in the restoration of the M063R open reading frame would be
able to form foci on RK13 cells. And the foci that grew and
were fluorescent in RK13 cells represented double recombi-
nants. These were selected and underwent multiple rounds of
plaque purification.
Growth curves
Viral replication was determined by single step growth
curves. BGMK or RK13 cells were infected at an moi=3 and
infected cells were collected at various times post infection.
Recovered virus was titrated onto BGMK cells and foci were
counted 48 hpi. Multi-step growth curves were used to
monitor virus spread. BGMK and RK13 cells (1×105 cells)
were infected with either vMyxgfp or vMyx63KO at an
moi=0.01. Infected cells were collected at 0, 12, 24, 24, 72,
96 h post infection and recovered virus was titrated onto
BGMK. Fluoresecent foci were enumerated and graphed using
Excel 2004 (Microsoft).Generation of polyclonal anti-M063R anti-serum
The peptide (KYYKVQNKGRLRMR) was selected for
synthesis because it represented a large predicted hydrophilic
region of M063R. The peptide was synthesized by Invitrogen
Inc. Rabbit polyclonal M063R antiserum was generated
using keyhole limpet hemocyanin (KLH)-conjugated peptide
as an immunogen. The peptide was conjugated to KLH using
the Imject Immunogen EDC conjugation kit (Pierce)
according to the manufacturer's recommendation. The first
injection into New Zealand white rabbits included the
antigen suspended in Fruend's complete adjuvant (Sigma)
followed by three boosts in Fruend's incomplete adjuvant
(Sigma). Positive anti-M063R anti-serum was determined by
Western blot analysis of BGMK infected lysates. Anti-serum
was purified by column affinity purification prepared with
the M063R peptide conjugated to BSA using the Aminolink
Plus Immobilization kit (Pierce) and following the manufac-
ture's instructions.
M063R pathogenesis study
Specific pathogen free (SPF) female New Zealand white
rabbits (O. cuniculus) were housed in the Level II biocontain-
ment facilities at the University of Western Ontario as per
Health Canada's and Canadian Food Inspection Agency
(CFIA) requirements. Each rabbit was injected subcutaneously
with 1000 pfu of the appropriate virus on each flank. The
rabbits were monitored daily by research and veterinary staff
for disease progression. Animals infected with vMyx63KO
were monitored for 16 days and then challenged with wildtype
MV and monitored for a further 21 days. Animals to be
sacrificed were injected with euthanyl intravenously following
anesthesia.
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